Browsing by Author Yuen, JCH

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 中
Showing results 55 to 74 of 75 < previous   next >
TitleAuthor(s)Issue DateViews
 
A randomized placebo-controlled, dose-finding study of oral LB80380 in HBeAg-positive patients with chronic hepatitis B
Journal:Antiviral Therapy
Yuen, MFKim, JKim, CRNgai, VYuen, JCHMin, CKang, HMShin, BSYoo, SDLai, CL
2006
141
 
Rebound of HBV DNA after cessation of nucleos/tide analogues in chronic hepatitis B patients with undetectable cccDNA
Proceeding/Conference:Hepatology
Lai, CLWong, DKHYuen, JCHWu, CHCheng, CTKNgai, WSKopaniszen, MSeto, WKWFung, JYYYuen, RMF
2017
60
 
Reduction of covalently closed circular DNA with long-term nucleos(t)ide analogue treatment in chronic hepatitis B
Journal:Journal of Hepatology
Lai, CLWong, DKHIp, PCPKopaniszen, MSeto, WKWFung, JYYHuang, FYLee, BCullaro, GChong, CKWu, CHCheng, CTKYuen, JCHNgai, WSYuen, RMF
2017
108
 
Reduction of hepatitis B core related antigen by long term nucleoside nucleotide analogue therapy and its correlation with intrahepatic HBV DNA reduction
Proceeding/Conference:Hepatology International
Wong, DKopaniszen, MSeto, WKFung, JHung, IYoung, JLPYuen, JCHNgai, VWSYuen, MFLai, CL
2015
248
 
Risk Factors and Post-Resection Independent Predictive Score for the Recurrence of Hepatitis B-Related Hepatocellular Carcinoma
Journal:PLoS ONE
Hung, FNIWong, DKHPoon, RTPFong, DYTChui, AHWSeto, WKWFung, JYYChan, ACYYuen, JCHTiu, TMRJCHOI, MYOLai, CLYuen, RMF
2016
89
 
Risk factors and post-resection independent predictive score for the recurrence of hepatitis B-related hepatocellular carcinoma
Proceeding/Conference:Hong Kong Medical Journal
Hung, IFNWong, DKHPoon, RTPFong, DYTChui, AHWSeto, WKFung, JYYChan, ACYYuen, JCHTiu, RChoi, OLai, CLYuen, MF
2015
46
 
Risk for hepatocellular carcinoma with respect to hepatitis B virus genotypes B/C, specific mutations of enhancer II/core promoter/precore regions and HBV DNA levels
Journal:Gut
Yuen, MFTanaka, YShinkai, NPoon, RTBut, DYKFong, DYTFung, JWong, DKHYuen, JCHMizokami, MLai, CL
2008
131
 
Role of HBV genotypes, core promoter/precore mutations and HBV DNA levels on hepatocarcinogenesis
Proceeding/Conference:Journal of Hepatology
Yuen, RMFTanaka, YShinkai, NPoon, RTPFung, JYYWong, DKHYuen, JCHMizokami, MLai, CL
2007
177
 
Role of hepatitis B virus genotypes Ba and C, core promoter and precore mutations on hepatocellular carcinoma: A case control study
Journal:Carcinogenesis
Yuen, MFTanaka, YMizokami, MYuen, JCHWong, DKHYuan, HJSum, SMChan, AOOWong, BCYLai, CL
2004
178
 
Screening of occult HBV infection in blood donors in Hong Kong using nucleic acid testing
Proceeding/Conference:Journal of Hepatology
Wong, DKHLai, CLFung, JYYLee, CKLin, CKHung, IFNBut, DHsu, AChan, PCheung, TKFung, FKCYuen, JCHYoung, JLPNgai, VWSYuen, RMF
2008
188
 
Sequential therapy using lamivudine in entecavir-treated patients with undetectable HBV DNA–results at 48 weeks
Proceeding/Conference:Hepatology
Fung, JYYLai, CLYuen, JCHCheng, CTKWu, CHYuen, RMF
2009
42
 
Serologic and virologic kinetics after stopping nucleoside analogue therapy in hepatitis B surface antigen (HBSAG) seroclearance
Proceeding/Conference:Journal of Hepatology
Seto, WKWong, DKHFung, JYuen, JCHHung, IFNLai, CLYuen, RMF
2012
531
 
Serum hepatitis B surface antigen (HBsAg) kinetics in hepatitis B e antigen (HBeAg)-negative chronic hepatitis B
Journal:Hepatology International
Seto, WKWong, DKHFung, JHung, IFNYuen, JCHTong, TLai, CLYuen, MF
2013
87
 
Serum hepatitis B surface antigen (HBSAG) titers and HBV DNA levels in Hepatitis B E antigen (HBEAG)-negative chronic Hepatitis B: an interim analysis
Proceeding/Conference:Hepatology
Seto, WKLai, CLFung, JWong, DYuen, JCHYoung, JLPTong, TSMHung, IFNYuen, MF
2011
39
 
Seven-Year Treatment Outcome of Entecavir in a Real-World Cohort: Effects on Clinical Parameters, HBsAg and HBcrAg Levels
Journal:Clinical and Translational Gastroenterology
Lam, YFSeto, WKWWong, DKHCheung, KSMFung, JYYMak, LYYuen, JCHChong, CKLai, CLYuen, RMF
2017
94
 
Significance of HBV DNA levels at 12 weeks of telbivudine treatment and the 3 years treatment outcome
Journal:Journal of Hepatology
Seto, WKLai, CLFung, JWong, DKHYuen, JCHHung, IFNYuen, MF
2011
166
 
Significance of HBV DNA levels in liver histology of HBeAg and anti-HBe positive patients with chronic hepatitis B
Journal:American Journal of Gastroenterology
Yuen, MFNg, IOLFan, STYuan, HJWong, DKHYuen, JCHSum, SSMChan, AOOLai, CL
2004
146
 
Three years of continuous entecavir therapy in treatment-nave chronic hepatitis B patients: VIRAL suppression, viral resistance, and clinical safety
Journal:American Journal of Gastroenterology
Yuen, MFSeto, WKFung, JWong, DKHYuen, JCHLai, CL
2011
108
 
Virological and clinico-pathological factors in predicting recurrence Hepatitis B related hepatocellular carcinoma after surgical resection
Proceeding/Conference:Annual Meeting of the Infectious Diseases Society of America, IDWeek 2013
Hung, IFNWong, DKHFong, DYTSeto, WKWFung, JYYYuen, JCHTiu, TMRJLai, CLPoon, RTPYuen, RMF
2013
40
 
Virological and clinico-pathological factors in predicting recurrence of Hepatitis B related hepatocellular carcinoma after surgical resection
Proceeding/Conference:Journal of Hepatology
Hung, IFNWong, DKHFong, DYTChui, AHSeto, WKWFung, JYYYuen, JCHTiu, TMRJTsoi, YYOLai, CLPoon, RTPYuen, RMF
2014
74
Showing results 55 to 74 of 75 < previous   next >